FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q37633455> ?p ?o ?g. }

• Q37633455 description "article científic" @default.
• Q37633455 description "article scientifique" @default.
• Q37633455 description "articolo scientifico" @default.
• Q37633455 description "artigo científico" @default.
• Q37633455 description "artículu científicu espublizáu en 2016" @default.
• Q37633455 description "bilimsel makale" @default.
• Q37633455 description "scientific article published on 06 October 2016" @default.
• Q37633455 description "vedecký článok" @default.
• Q37633455 description "vetenskaplig artikel" @default.
• Q37633455 description "videnskabelig artikel" @default.
• Q37633455 description "vědecký článek" @default.
• Q37633455 description "wetenschappelijk artikel" @default.
• Q37633455 description "wissenschaftlicher Artikel" @default.
• Q37633455 description "наукова стаття, опублікована в жовтні 2016" @default.
• Q37633455 description "научни чланак" @default.
• Q37633455 description "مقالة علمية نشرت في 06 أكتوبر 2016" @default.
• Q37633455 name "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 name "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 name "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 type Item @default.
• Q37633455 label "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 label "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 label "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 prefLabel "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 prefLabel "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 prefLabel "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 P1433 Q37633455-7D8D6774-04B2-40D5-9748-E371E92F4E0D @default.
• Q37633455 P1476 Q37633455-423EC8ED-09AF-479F-A0B4-8EBEDC176F18 @default.
• Q37633455 P2093 Q37633455-03A2AE45-170A-4BAD-8C78-F3764E2F3DBD @default.
• Q37633455 P2093 Q37633455-0F745AA2-D4AE-4A42-BC00-E8D61B23C450 @default.
• Q37633455 P2093 Q37633455-731B97A5-FF62-4E15-8EED-83401D01E3AC @default.
• Q37633455 P2093 Q37633455-9A5A32B2-8BDC-456D-8194-870495F193D7 @default.
• Q37633455 P2093 Q37633455-B616ECC9-E666-4300-9B25-FCF7234D8CAE @default.
• Q37633455 P2860 Q37633455-06E0F4D4-BCCF-442E-BE6C-0DFDEC7CFB90 @default.
• Q37633455 P2860 Q37633455-08F5B4A9-B9E6-467C-B244-9B3CC79D15CF @default.
• Q37633455 P2860 Q37633455-0DA906D2-334C-4546-9981-EFF49671EE7B @default.
• Q37633455 P2860 Q37633455-11917CAE-2925-45CA-B8A5-957133DA6FF2 @default.
• Q37633455 P2860 Q37633455-120AC120-489A-4B48-9249-349A96A8A874 @default.
• Q37633455 P2860 Q37633455-36A191AA-42F9-4DAF-B1FB-F1AAB596BA21 @default.
• Q37633455 P2860 Q37633455-4F69D51A-FB8D-491D-BDF8-D7EC9CF12A4B @default.
• Q37633455 P2860 Q37633455-58017579-A6CF-4285-A11C-5005A9F7B375 @default.
• Q37633455 P2860 Q37633455-5EDBACE5-8256-4834-9BE5-EABB4C6DEDE1 @default.
• Q37633455 P2860 Q37633455-66E1E9F0-2949-4A5D-9C56-FD86A79F073C @default.
• Q37633455 P2860 Q37633455-674609AB-FD39-4A92-A221-8ACEFB145CB5 @default.
• Q37633455 P2860 Q37633455-6ECDD28B-7F99-433F-9968-3A25694B5ADA @default.
• Q37633455 P2860 Q37633455-7B07D200-56A2-4633-B9C1-3ADFEA043E2C @default.
• Q37633455 P2860 Q37633455-8FC110D9-5A0D-4A69-AB1A-EC0A80A5D583 @default.
• Q37633455 P2860 Q37633455-92F37F07-9ACD-4C7D-A57B-43F980D5A362 @default.
• Q37633455 P2860 Q37633455-97B68A3E-6D8C-4B69-86E9-D3A9D68F7031 @default.
• Q37633455 P2860 Q37633455-A2E6C51D-DA9F-4D3E-A582-4A765DFB6A79 @default.
• Q37633455 P2860 Q37633455-B51FF6E8-36EC-48D2-BF68-DB0D0173CFAA @default.
• Q37633455 P2860 Q37633455-D23D8908-3EAF-401A-ACBF-FAFEE1BDD2BA @default.
• Q37633455 P2860 Q37633455-DA1DF039-FD3D-4494-9136-5D6C37ABCBDC @default.
• Q37633455 P2860 Q37633455-EBCCD408-2F32-4383-8BC9-DB9B203A722B @default.
• Q37633455 P2860 Q37633455-F48850F0-04C0-43B4-93BC-1ACA5B3D20DF @default.
• Q37633455 P304 Q37633455-1CE25431-0806-4E81-834A-2EB6C490917C @default.
• Q37633455 P31 Q37633455-ACCA9D86-12A1-4720-8E95-9ACB703E1A9E @default.
• Q37633455 P356 Q37633455-34BB7E18-B9BA-4698-AA06-99D2385A7060 @default.
• Q37633455 P433 Q37633455-9212562C-F49A-48FC-B8B4-FF17877AB322 @default.
• Q37633455 P478 Q37633455-749A9610-3D5B-456C-A987-A825F320AF71 @default.
• Q37633455 P577 Q37633455-AC995276-DC5D-4C24-A5A0-57818DF6B70B @default.
• Q37633455 P698 Q37633455-92ED598F-C5C6-4A5B-BA26-7BBEAD340151 @default.
• Q37633455 P921 Q37633455-35D1A9BD-D524-4300-A2A2-A0E32BE7A0E5 @default.
• Q37633455 P921 Q37633455-ABA6850E-4041-456F-8A72-6CFA4ABD0A23 @default.
• Q37633455 P921 Q37633455-B903175F-54CC-44D7-A3AC-643F21EDCF10 @default.
• Q37633455 P932 Q37633455-103C6145-2C77-4D61-B7ED-35B1ED5583CA @default.
• Q37633455 P356 DOM.12803 @default.
• Q37633455 P698 27709762 @default.
• Q37633455 P1433 Q5270109 @default.
• Q37633455 P1476 "Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial" @default.
• Q37633455 P2093 "Eric Zijlstra" @default.
• Q37633455 P2093 "Hanne Haahr" @default.
• Q37633455 P2093 "Leszek Nosek" @default.
• Q37633455 P2093 "Tim Heise" @default.
• Q37633455 P2093 "Tord Rikte" @default.
• Q37633455 P2860 Q28085428 @default.
• Q37633455 P2860 Q34113920 @default.
• Q37633455 P2860 Q35563643 @default.
• Q37633455 P2860 Q35767678 @default.
• Q37633455 P2860 Q35918397 @default.
• Q37633455 P2860 Q36108419 @default.
• Q37633455 P2860 Q37275651 @default.
• Q37633455 P2860 Q37320243 @default.
• Q37633455 P2860 Q37816710 @default.
• Q37633455 P2860 Q37982891 @default.
• Q37633455 P2860 Q38025029 @default.
• Q37633455 P2860 Q38037727 @default.
• Q37633455 P2860 Q38148670 @default.
• Q37633455 P2860 Q38229246 @default.
• Q37633455 P2860 Q38496188 @default.
• Q37633455 P2860 Q38631154 @default.
• Q37633455 P2860 Q38652925 @default.
• Q37633455 P2860 Q44333619 @default.
• Q37633455 P2860 Q46452341 @default.
• Q37633455 P2860 Q48932220 @default.
• Q37633455 P2860 Q51480316 @default.
• Q37633455 P2860 Q85377341 @default.
• Q37633455 P304 "208-215" @default.
• Q37633455 P31 Q13442814 @default.
• Q37633455 P356 "10.1111/DOM.12803" @default.

• next